| Issue | Title | |
| Vol 17, No 2 (2024) | Clinical and economic assessment of using topical bacterial lysate Imudon® for the treatment and prevention of acute upper respiratory tract infections in children | Abstract PDF (Rus) |
| A. R. Kasimova, A. S. Kolbin | ||
| Vol 5, No 3 (2012) | CLINICAL AND ECONOMIC BENEFITS OF HUMAN INSULIN ANALOGUESUSE | Abstract PDF (Rus) |
| E. E. Arinina, M. A. Rashyd | ||
| Vol 14, No 1 (2021) | Clinical and economic constituents of the application of dexamethasone and tocilizumab in the therapy for severe conditions in patients with COVID-19 | Abstract PDF (Rus) |
| O. V. Zhukova, A. L. Khokhlov | ||
| Vol 11, No 2 (2018) | Clinical and economic efficiency of the loop ileostomy closure by various methods | Abstract PDF (Rus) |
| A. V. Veselov, S. I. Achkasov, O. I. Sushkov, A. I. Moskalev, I. S. Lantsov | ||
| Vol 18, No 2 (2025) | Clinical and economic evaluation of antibacterial therapy for nosocomial pneumonia on the example of a multidisciplinary hospital in Moscow | Abstract PDF (Rus) |
| D. D. Ivanova, I. N. Sychev, N. B. Lazareva | ||
| Vol 10, No 2 (2017) | CLINICAL AND ECONOMIC EVALUATION OF CHRONIC DISEASE TREATMENT: A DISCREPANCY BETWEEN THE TRADITIONAL PHARMACOECONOMIC AND SOCIO-ECONOMIC ANALYSES | Abstract PDF (Rus) |
| O. V. Zhukova, S. V. Kononova | ||
| Vol 10, No 1 (2017) | CLINICAL AND ECONOMIC EVALUATION OF ERIBULIN EFFECTIVENESS IN SOFT TISSUE SARCOMA: RESULTS OF META-ANALYSIS | Abstract PDF (Rus) |
| P. V. Мazin, I. V. Sheshunov, N. K. Mazina, E. M. Markova | ||
| Vol 7, No 2 (2014) | CLINICAL AND ECONOMIC EVALUATION OF IVABRADINE USE IN STABLE ANGINA IN TERMS OF REPUBLIC OF BELARUS HEALTH CARE SYSTEM | Abstract PDF (Rus) |
| I. N. Kozhanova, I. S. Romanova, L. N. Gavrilenko, A. V. Patseev, M. M. Sachek | ||
| Vol 9, No 3 (2016) | CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY | Abstract PDF (Rus) |
| E. A. Pyadushkina, M. Yu. Frolov | ||
| Vol 8, No 4 (2015) | CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS | Abstract PDF (Rus) |
| E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva | ||
| Vol 17, No 1 (2024) | Clinical and economic implications of using daratumubab with lenalidomide in the 1st and 2nd lines of therapy for multiple myeloma patients | Abstract PDF (Rus) |
| О. I. Ivakhnenko, V. V. Ryazhenov, N. A. Falaleeva | ||
| Vol 11, No 4 (2018) | Clinical and economic studies on pharmacotherapy of malignant neoplasms: the modeling approach | Abstract PDF (Rus) |
| A. G. Tolkushin, S. K. Zyryanov, N. L. Pogudina, M. V. Davydovskaya | ||
| Vol 7, No 1 (2014) | CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT | Abstract PDF (Rus) |
| I. I. Shteynberg, S. K. Zyryanov, Yu. B. Belousov | ||
| Vol 16, No 1 (2023) | Clinical approbation today: analysis of current problems and solutions | Abstract PDF (Rus) |
| V. V. Omelyanovskiy, D. V. Lukyantseva, T. I. Alekseeva, Yu. V. Voropaeva, T. A. Tomilina, R. A. Teryan, A. O. Gadzhieva | ||
| Vol 8, No 2 (2015) | CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA | Abstract PDF (Rus) |
| Elena Albertovna Sobko, Natalya Vladimirovna Gordeeva, Angelina Yurievna Kraposhina, Irina Anatolyevna Soloveva, Svetlana Vladimirovna Chubarova, Olga Petrovna Ishenko, Irina Vladimirovna Demko, Maria Michailovna Loktionova | ||
| Vol 15, No 2 (2022) | Clinical study of real-time polymerase chain reaction test kit for SARS-CoV-2 ribonucleic acids detection | Abstract PDF (Rus) |
| M. Yu. Dmitryukova, A. A. Golod, M. E. Senina, A. E. Gushchin | ||
| Vol 11, No 2 (2018) | Comments to the article by O. Yu. Rebrova and co-authors «Screening at the first stage of periodical health checkup: a systematic review of long-term results» | Abstract PDF (Rus) |
| V. A. Aksenov | ||
| Vol 12, No 3 (2019) | Comorbidity in elderly patients with atrial fibrillation affects the “cost of illness” | Abstract PDF (Rus) |
| S. V. Malchikova , N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva | ||
| Vol 13, No 3 (2020) | Comparative analysis of antipsychotic drug consumption for inpatient schizophrenia treatment: a retrospective study with 5-year follow-up | Abstract PDF (Rus) |
| L. B. Vaskova, M. V. Tiapkina, E. V. Mikhaylenko | ||
| Vol 16, No 3 (2023) | Comparative analysis of using atezolizumab vs. durvalumab in combination with platinum-containing chemotherapy in adult patients with advanced small cell lung cancer | Abstract PDF (Rus) |
| I. S. Krysanov, E. V. Makarova, V. Yu. Ermakova | ||
| Vol 16, No 4 (2023) | Comparative chemomicrobiomic analysis of bacteriocins | Abstract PDF (Rus) |
| I. Yu. Torshin, O. A. Gromova | ||
| Vol 9, No 1 (2016) | COMPARATIVE CLINICAL AND ECONOMIC ANALYSIS OF THE INTENSIFICATION THERAPY IN PATIENTS WITH UNCONTROLLED DIABETES TYPE 2 USING BASAL INSULIN OR DAPAGLIFLOZIN | Abstract PDF (Rus) |
| V. I. Petrov, S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova, V. Yu. Khripaeva | ||
| Vol 12, No 4 (2019) | Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis | Abstract PDF (Rus) |
| I. V. Sarvilina, A. N. Galustyan, A. K. Hadzhidis, I. S. Sardaryan, N. V. Lavrov, O. A. Gromova, Yu. S. Prokofieva | ||
| Vol 10, No 2 (2017) | COMPARATIVE COST-MINIMIZATION AND BUDGET-IMPACT ANALYSIS OF FIXED-DOSE INHALED CORTICOSTEROID / LONG-ACTING BETAAGONIST COMBINATIONS IN THE TREATMENT OF ASTHMA | Abstract PDF (Rus) |
| N. L. Pogudina, E. G. Kosolapov, F. S. Kochenkov, A. V. Karaulov, N. L. Bondarenko, D. V. Blinov | ||
| Vol 14, No 2 (2021) | Comparative effectiveness of simultaneous and staged operations in patients with atherosclerotic lesions of carotid and coronary arteries | Abstract PDF (Rus) |
| A. B. Ismoilova, N. M.U. Sultanbaeva, A. A. Abdurakhmanov, Sh. Z. Umarova, D. Kh. Dzhalalova, S. Ch. Dzhalalov | ||
| Vol 18, No 1 (2025) | Comparative estimation of the effectiveness of the Khorana, Vienna CATS, and TiC-Onco scores and the vWF/ADAMTS13 ratio in identifying a high risk of thrombotic complications in patients with malignant neoplasms | Abstract PDF (Rus) |
| A. V. Vorobеv, A. G. Solopova, V. O. Bitsadze, M. M. Baeva, M. E. Sosnyagova, V. N. Galkin, D. O. Utkin, A. D. Makatsariya | ||
| Vol 12, No 2 (2019) | Comparative modeling of socio-economic burden among smokers, nonsmokers and former smokers | Abstract PDF (Rus) |
| E. V. Radchenko, A. S. Kolbin | ||
| Vol 16, No 2 (2023) | Comparative pharmacoeconomic analysis of follitropin delta application for superovulation induction during artificial insemination | Abstract PDF (Rus) |
| I. S. Krysanov, V. S. Krysanova, V. Yu. Ermakova | ||
| Vol 10, No 3 (2017) | Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients | Abstract PDF (Rus) |
| N. K. Mazina, P. V. Mazin | ||
| Vol 8, No 3 (2015) | COMPARATIVE PHARMACOECONOMIC STUDY OF VITAMIN-MINERAL COMPLEXES FOR REHABILITATION DURING THE PERIOD OF INCREASED NEEDS FOR MICRONUTRIENTS | Abstract PDF (Rus) |
| A. Yu. Belinskaya, I. Yu. Torshin, T. R. Grishina, O. A. Gromova | ||
| Vol 9, No 4 (2016) | COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY | Abstract PDF (Rus) |
| V. S. Dombrovskiy, G. R. Khachatryan | ||
| Vol 17, No 1 (2024) | Compounding pharmacy regulations: experience of the Latvian pharmaceutical market | Abstract PDF (Rus) |
| D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich | ||
| Vol 16, No 1 (2023) | Compounding pharmacy regulations: experience of the North American pharmaceutical market | Abstract PDF (Rus) |
| D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich | ||
| Vol 18, No 2 (2025) | Comprehensive analysis of the interrelationships between somatometric, biochemical, and clinical indicators reflecting the condition of patients with chronic kidney disease | Abstract PDF (Rus) |
| I. Yu. Torshin, N. Z. Bashun, O. A. Gromova, A. V. Chekel, A. A. Levchuk, S. N. Lazarevich | ||
| Online First | Computer vision programs in medicine: dataset development, classification, and clinical use | Abstract PDF (Rus) |
| D. I. Korabelnikov, A. I. Lamotkin | ||
| Vol 1, No 19 (2026) | Computer-based systematic analysis of fundamental and clinical studies on the pharmacology of alloferon | Abstract PDF (Rus) |
| O. A. Gromova, I. Yu. Torshin | ||
| Vol 15, No 4 (2022) | Concentration of vitamin D metabolite – 25(OH)D3 as a predictor of breast cancer progression | Abstract PDF (Rus) |
| D. Е. Frolova, N. P. Lapochkina, О. А. Gromova, I. Yu. Torshin | ||
| Vol 13, No 4 (2020) | Concept of value-based healthcare | Abstract PDF (Rus) |
| N. Z. Musina, V. V. Omelyanovskiy, R. V. Gostischev, O. A. Sukhorukikh, V. K. Fedyaeva, N. N. Sisigina, D. G. Shchurov | ||
| Vol 1, No 19 (2026) | Concepts aimed at improving pharmaceutical care for patients with socially significant diseases in Russia and worldwide | Abstract PDF (Rus) |
| Yu. Sh. Gushchina, A. Yu. Abramov | ||
| Vol 12, No 2 (2019) | Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine | Abstract PDF (Rus) |
| I. Yu. Torshin, O. A. Gromova, Zh. D. Kobalava | ||
| Vol 18, No 3 (2025) | Convolutional neural networks and transformers in skin tumor diagnostics: a comparative analysis of the efficiency of artificial intelligence models in computer vision programs | Abstract PDF (Rus) |
| A. I. Lamotkin, D. I. Korabelnikov | ||
| Vol 9, No 3 (2016) | COPAYMENTS OF THE CITIZENS IN HEALTHCARE SYSTEM: INTERNATIONAL PRACTICE | Abstract PDF (Rus) |
| A. P. Tatarinov, D. V. Lukyantseva, L. S. Melnikova, V. V. Omelyanovskii | ||
| Vol 18, No 2 (2025) | Cosmetics as a product group of the Russian pharmaceutical market: analysis of competition and level of dominance | Abstract PDF (Rus) |
| N. I. Markov, L. S. Treshchetkina | ||
| Vol 18, No 3 (2025) | Cost and clinical effectiveness of fixed-dose combination therapies in the treatment of glaucoma patients: a systematic review | Abstract PDF (Rus) |
| Sh. Z. Umarova, Z. R. Usmonova, N. M. Normatova, N. M. Sultanbayeva | ||
| Vol 5, No 2 (2012) | COST EFFECTIVENESS OF ORAL PERICALCITOL IN PATIENTS WITH STAGE III-IV CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYREOSIS | Abstract PDF (Rus) |
| A. V. Rudakova | ||
| Vol 9, No 4 (2016) | COST MINIMIZATION SHALL NOT KILL PEOPLE FINAL RELEASE OF VII RUSSIAN CONGRESS OF PATIENTS | Abstract PDF (Rus) |
| Editorial article | ||
| Vol 5, No 1 (2012) | COST OF ILLNESS ANALYSIS: TYPES, METHODOLOGY, RUSSIAN SPECIFICS | Abstract |
| R. I. Yagudina, I. Yu. Zinchuk, M. M. Litvinenko | ||
| Vol 17, No 2 (2024) | Cost-effectiveness analysis of acalabrutinib in treatment of patients with relapsed/refractory form of mantle cell lymphoma who previously received at least one line of therapy | Abstract PDF (Rus) |
| S. K. Zyryanov, I. N. Dyakov | ||
| Vol 9, No 1 (2016) | COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA | Abstract PDF (Rus) |
| G. R. Khachatryan, D. V. Fedyaev, M. V. Avxentyeva, V. S. Dombrovskiy | ||
| Vol 16, No 3 (2023) | Cost-effectiveness analysis of encorafenib and binimetinib combination as first-line treatment for metastatic or unresectable BRAF V600-mutated metastatic melanoma in Russia | Abstract PDF (Rus) |
| N. A. Avxentyev, Yu. V. Makarova | ||
| 101 - 150 of 585 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |
Browse Title Index
Popular articles
Vol 17, No 2 (2024)
Vol 17, No 3 (2024)
Vol 10, No 1 (2017)
Vol 16, No 3 (2023)
Vol 16, No 4 (2023)
Vol 14, No 4 (2021)
Keywords
COVID-19
artificial intelligence
budget impact
budget impact analysis
chemotherapy
chondroitin sulfate
clinical and economic analysis
cost minimization analysis
cost-effectiveness analysis
evidence-based medicine
glucosamine sulfate
health technology assessment
oncology
pharmaceutical market
pharmacoeconomic analysis
pharmacoeconomic modeling
pharmacoeconomics
pharmacoepidemiology
pharmacoinformatics
quality of life
systematic review
Publisher: IRBIS LLC
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
